Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Liabilities and Shareholders Equity (2016 - 2025)

Cosmos Health (COSM) has disclosed Liabilities and Shareholders Equity for 13 consecutive years, with $69.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity rose 7.71% year-over-year to $69.5 million, compared with a TTM value of $242.8 million through Sep 2025, down 4.29%, and an annual FY2024 reading of $54.3 million, down 17.73% over the prior year.
  • Liabilities and Shareholders Equity was $69.5 million for Q3 2025 at Cosmos Health, up from $61.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $71.5 million in Q3 2023 and bottomed at $41.7 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $57.9 million, with a median of $60.8 million recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity soared 77.64% in 2021, then fell 17.73% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $49.4 million in 2021, then surged by 37.65% to $68.0 million in 2022, then fell by 2.97% to $66.0 million in 2023, then dropped by 17.73% to $54.3 million in 2024, then increased by 27.95% to $69.5 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for COSM at $69.5 million in Q3 2025, $61.8 million in Q2 2025, and $57.2 million in Q1 2025.